You have 9 free searches left this month | for more free features.

Linker

Showing 26 - 50 of 155

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)

Recruiting
  • Large B-cell Lymphoma
  • DLBCL
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 12, 2023

Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

Terminated
  • Acute Lymphocytic Leukemia
  • Adult Lymphoblastic Lymphoma
  • La Jolla, California
  • +3 more
Apr 26, 2022

Heart Failure Trial in Assuan (Dapagliflozin, insulin)

Completed
  • Heart Failure
  • Assuan, Egypt
    Assiut University
Feb 15, 2022

Chronic Kidney Disease, Dialysis, Kidney Transplant Trial in Danville (Observational study - registry)

Recruiting
  • Chronic Kidney Disease
  • +3 more
  • Observational study - registry
  • Danville, Pennsylvania
    Geisinger Clinic
Aug 9, 2022

Axial Spondyloarthritis, Psoriatic Arthritis Trial in Istanbul (serum raftlin-1 protein levels)

Recruiting
  • Axial Spondyloarthritis
  • Psoriatic Arthritis
  • serum raftlin-1 protein levels
  • Istanbul, Turkey
    Bezmialem University
Mar 22, 2023

HIV Trial in United States (FP conjugate vaccine (25 mcg), FP conjugate vaccine (200 mcg), Trimer 6931 (100 mcg))

Not yet recruiting
  • HIV
  • FP conjugate vaccine (25 mcg)
  • +5 more
  • Los Angeles, California
  • +6 more
Jul 19, 2022

Breast Cancer Trial in China (TQB2102 for injection)

Not yet recruiting
  • Breast Cancer
  • TQB2102 for injection
  • Hefei, Anhui, China
  • +20 more
Nov 1, 2023

Home Environment of Patients With Multiple Sclerosis

Recruiting
  • Multiple Sclerosis
    • Regensburg, Bavaria, Germany
      Department of Neurology, University of Regensburg
    Apr 12, 2021

    Prostate Cancer Trial in Beijing (11C-Choline)

    Recruiting
    • Prostate Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 11, 2021

    Heart Failure With Preserved Ejection Fraction Trial in Madrid

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
      • Madrid, Spain
        Hospital Universitario Ramón y Cajal
      Aug 16, 2023

      Metastatic Breast Cancer Trial in Japan, United States (Patritumab Deruxtecan)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Patritumab Deruxtecan
      • Newnan, Georgia
      • +25 more
      Dec 5, 2022

      Myoma;Uterus, IVF, Surgery Trial (myomectomy or not)

      Not yet recruiting
      • Myoma;Uterus
      • +2 more
      • myomectomy or not
      • (no location specified)
      Jul 6, 2023

      Heart Failure Trial in Worldwide (Quadripolar LV Lead)

      Recruiting
      • Heart Failure
      • Quadripolar LV Lead
      • Anchorage, Alaska
      • +114 more
      Aug 9, 2022

      Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

      Not yet recruiting
      • Stem Cell Transplant Complications
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jul 17, 2022

      Urothelial Carcinoma Trial in Milan (Sacituzumab govitecan)

      Recruiting
      • Urothelial Carcinoma
      • Sacituzumab govitecan
      • Milan, Italy
        IRCCS Ospedale San Raffaele
      Feb 7, 2022

      Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)

      Recruiting
      • Epithelial Ovarian Cancer
      • +2 more
      • Mirvetuximab Soravtansine
      • Bengbu, Anhui, China
      • +27 more
      Nov 14, 2022

      Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

      Not yet recruiting
      • Breast Cancer
      • Metastatic Breast Cancer
      • Trastuzumab-Deruxtecan (T-DXd)
      • (no location specified)
      Sep 20, 2023

      Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

      Recruiting
      • Solid Tumor, Adult
      • +11 more
      • New Haven, Connecticut
      • +3 more
      May 9, 2022

      Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, NSCLC Stage IV Trial in Australia, United States (IMU-201

      Recruiting
      • Non Small Cell Lung Cancer
      • +5 more
      • IMU-201 (administered as PD1-Vaxx)
      • Phoenix, Arizona
      • +5 more
      Jan 19, 2022

      Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

      Completed
      • Epithelial Ovarian Cancer
      • +2 more
      • Mirvetuximab Soravtansine
      • Phoenix, Arizona
      • +88 more
      Jan 19, 2023

      Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in United States (U3-1402)

      Recruiting
      • Metastatic Breast Cancer
      • Locally Advanced Breast Cancer
      • Birmingham, Alabama
      • +9 more
      Jul 18, 2022

      Immune System Diseases Trial (Strimvelis)

      Withdrawn
      • Immune System Diseases
      • Strimvelis
      • (no location specified)
      Jul 13, 2020

      Severe Pneumonia Trial in Changzhou, Nanjing, Suzhou (SSBD(PCR-CRISPR/Cas12a))

      Not yet recruiting
      • Severe Pneumonia
      • SSBD(PCR-CRISPR/Cas12a)
      • Changzhou, Jiangsu, China
      • +4 more
      May 8, 2022